Followers | 180 |
Posts | 17849 |
Boards Moderated | 1 |
Alias Born | 11/19/2013 |
Friday, February 01, 2019 4:29:14 PM
https://www.otcmarkets.com/filing/html?id=13158484&guid=7_TtUnejEdsCh3h
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 15, 2019, Mr. Marino Papazoglou, was appointed as new director by the company’s Board of Directors, effective immediately. Mr. Papazoglou will be paid stock compensation base on business progress. Mr. Papazoglou was granted 50,000 shares of restricted common stock per year for three years as stock compensation at the time of his appointment. The restricted stock has a value of $0.036 per share based on stock market price at stock grant date.
On January 15, 2019, Mr. Brian Cheng was appointed as new directors by the company’s Board of Directors, effective immediately. Mr. Brian Cheng will be paid stock compensation base on business progress. Mr. Cheng was granted 100,000 shares of restricted common stock per year for three years as stock compensation at the time of his appointment. The restricted stock has a value of $0.036 per share based on stock market price at stock grant date.
On January 15, 2019, the company renewed agreement with its three existing officers/directors. The company will differ salary compensation to the three officers/ directors until the company has significantly expanded its operation. At the time of agreement, the company granted the CEO, Ms. Li Yan, 200,000 shares of restricted common stock per year for three years. The company granted the CFO, Mr. Lei Wang, 100,000 shares of restricted common stock per year for three years and granted the Secretary/Treasurer, Mr. Kecheng Xu, 50,000 shares of restricted common stock per year for three years as stock compensation. The restricted compensation stock has a value of $0.036 per share based on stock market price at stock grant date.
Item 3.02. Unregistered Sales of Equity Securities.
On January 15, 2019, Mr. Marino Papazoglou was granted 50,000 restricted stock per year for three years upon his appointment as new director of the board.
On January 15, 2019, Mr. Mr. Brian Cheng was granted 100,000 restricted stock per year for three years upon his appointment as new director of the board.
On January 15, 2019, Ms. Li Yan, was granted 200,000 restricted stock per year for three years upon new compensation agreement.
On January 15, 2019, Mr. Lei Wang, was granted 100,000 restricted stock per year for three years based on new compensation agreement.
On January 15, 2019, Mr. Kecheng Xu, was granted 50,000 restricted stock per year for three years based on new compensation agreement.
The shares of common stock described above were not registered under the Securities Act of 1933 and are restricted securities. The shares were issued pursuant to the registration exemption afforded the company under Section 4(2) of the Securities Act. Each of Messrs. Wang and Xu acquired these shares for their own account. The certificates representing these shares will bear a restricted legend providing that they cannot be sold except pursuant to an effective registration statement or an exemption from registration.
Recent JFIL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2024 06:33:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/02/2023 02:56:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/07/2023 04:57:09 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM